-
Product Insights
NewANGLE Plc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our ANGLE Plc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment and monitoring of disease. Its product Parsortix cell separation system, which captures very rare circulating tumor cells in cancer patient blood....
-
Product Insights
NewArcherDx Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our ArcherDx Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. ArcherDx Inc (ArcherDx) is a molecular technology company that develops customized genomic medicine-based solutions for the discovery of various types of cancer, auto-immune, and other genetic diseases. It offers comprehensive next-generation sequencing (NGS) assays that enable the detection of deoxyribonucleic acid (DNA)-based variant and copy-number variation (CNV); sensitive variant from circulating tumor (ct) DNA; ribonucleic acid (RNA)-based fusion, expression and...
-
Product Insights
NewBiofourmis Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Biofourmis Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Biofourmis Inc (Biofourmis) is a provider of advanced technology and clinical support for home care and digital therapies. The company offers Care@Home platform to deliver virtual care for patients with acute, post-acute, and chronic medical conditions; and software-based therapeutics to treat and manage patients with unmet clinical needs. Its DCT (decentralized clinical trials) solution provides telehealth, active ePRO and passive...
-
Product Insights
NewCellSeed Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our CellSeed Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. CellSeed Inc (CellSeed) is biotechnology company. It offers various products such as epithelial cell sheet for corneal regeneration, regenerated cardiac patch, epithelial cell sheet for esophageal regeneration, cell sheet for periodontal tissue regeneration and regenerated cartilage sheet. The company toffers temperature-responsive cell cultureware for cell-sheet engineering, cell cutureware for cell collection and low cell binding cultureware. CellSeed’s UpCell finds application...
-
Product Insights
NewCepheid Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Cepheid Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Cepheid Inc (Cepheid), a subsidiary of Danaher Corp, is a molecular diagnostic company that develops, manufactures, and markets molecular systems and conducts tests for clinical and non-clinical markets. The company offers in vitro diagnostic tests for health care associated infections, critical infectious diseases, sexual health, virology, oncology and genetics; molecular diagnostic systems; and reagents and parts. Cepheid distributes its products...
-
Product Insights
NewCytoSorbents Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our CytoSorbents Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company. The company develops blood purification products. It offers products like cytosorb, hemodefend, ecos-300cy, drugsorb-ATR, vetresq. CytoSorbents flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriously ill patients by reducing excessive cytokines and bacterial toxins. It’s CytoSorb is also...
-
Product Insights
NewDiaCarta Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our DiaCarta Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. DiaCarta Inc (DiaCarta) is a developer of molecular diagnostics products for cancer and infectious diseases. The company offers genomic testing for biomarkers and also provides clinical sample testing services in their CLIA-certified lab. It offers products such as gene mutation detection kits, colon cancer tests, fusion gene detection tests, adapter dimer removal, DNA sample card, CRISPR gene editing, PCR ready...
-
Product Insights
NewDiamiR LLC Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our DiamiR LLC Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. DiamiR LLC (DiamiR) is a medical device company. The company is involved in the development and commercialization of technology based on analysis of brain-enriched microRNA biomarkers in blood plasma to be used for screening, early and differential diagnosis. It offers microRNAs that are a class of small non-coding regulatory RNA molecules, which modulate target gene expression and protein production. DiamiR...
-
Product Insights
NewScailyte AG Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Scailyte AG Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Scailyte AG(Scailyte ) is a Switzerland based developer of artificial intelligence (AI) based software for pharmaceutical discovery, biomedical research and precision diagnostics. Scailyte is headquartered in Sursee, Switzerland. GlobalData's Medical Devices company profile report, “Scailyte AG Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile report provides key...
-
Product Insights
NewAffera Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Affera Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Affera Inc (Affera) is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia, a prevalent condition affecting millions of patients worldwide. Affera is headquartered in Watertown, Massachusetts, the US. GlobalData's Medical Devices company profile report, “Affera Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline...